Alpha Teknova (TKNO) Non-Current Assets (2020 - 2026)

Alpha Teknova's (TKNO) quarterly Non-Current Assets came in at $67.0 million in Q1 2026, down 9.8% year-on-year from $74.3 million in Q1 2025, and down 3.03% on a QoQ basis from $69.1 million in Q4 2025.

Alpha Teknova (TKNO) Non-Current Assets (2020 - 2026) Analysis & Trends

Alpha Teknova (TKNO) has 7 years of Non-Current Assets data on file, last reported at $67.0 million in Q1 2026.

  • On a quarterly basis, Non-Current Assets fell 9.8% year-over-year to $67.0 million in Q1 2026; TTM through Mar 2026 was $279.5 million, a 9.38% decrease from a year earlier, with the FY2025 full-year figure at $69.1 million, down 9.11% from the prior year.
  • Non-Current Assets for Q1 2026 stood at $67.0 million, down from $69.1 million in the prior quarter.
  • Over the last five years, Non-Current Assets for TKNO reached as high as $101.9 million in Q2 2022 and fell as low as $67.0 million in Q1 2026.
  • Historically, Non-Current Assets has averaged $82.1 million across 5 years, with a median of $82.0 million in 2024.
  • Across the five-year window, Non-Current Assets jumped 87.89% in 2022 and decreased 12.25% in 2023, its largest moves.
  • Year by year, Non-Current Assets stood at $91.1 million in 2022, then retreated by 8.99% to $82.9 million in 2023, then retreated by 8.36% to $76.0 million in 2024, then slipped by 9.11% to $69.1 million in 2025, then fell by 3.03% to $67.0 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $67.0 million in Q1 2026, $69.1 million in Q4 2025, and $71.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Alpha Teknova 278.75 Mn 260.97 Mn 3.78 Mn 66.98 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 66.98 Mn
Dec 31, 2025 69.07 Mn
Sep 30, 2025 71.06 Mn
Jun 30, 2025 72.43 Mn
Mar 31, 2025 74.26 Mn
Dec 31, 2024 75.99 Mn
Sep 30, 2024 78.17 Mn
Jun 30, 2024 80.07 Mn
Mar 31, 2024 81.99 Mn
Dec 31, 2023 82.93 Mn
Sep 30, 2023 87.31 Mn
Jun 30, 2023 89.44 Mn
Mar 31, 2023 91.39 Mn
Dec 31, 2022 91.12 Mn
Sep 30, 2022 90.21 Mn
Jun 30, 2022 101.92 Mn
Mar 31, 2022 92.15 Mn
Dec 31, 2021 65.31 Mn
Sep 30, 2021 58.08 Mn
Jun 30, 2021 54.25 Mn